Nasal Tramadol delivery system: A new approach for improved pain therapy

European Journal of Pain Supplements

Volumn 5, Issue 2, 2011, Pages 449-452

  Duchi, Shaher ^a   Touitou, Elka ^a   Pradella, Lorenzo ^b   Marchini, Francesco ^b   Ainbinder, Denize ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b NONE

Author keywords

Analgesia; Nasal delivery system; Pain; Tramadol

Indexed keywords

TRAMADOL;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG SAFETY; LAMINA PROPRIA; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; NOSE CAVITY; PRIORITY JOURNAL; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 83355177368     PISSN: 17543207     EISSN: 18780075     Source Type: Journal    
DOI: 10.1016/j.eujps.2011.08.009     Document Type: Article

References (7)

1. Collier H.O., Dinneen L.C., Johnson C.A., Schneider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol Chemother 1968, 32:295-310.
2. Dursteler C., Mases A., Fernandez V., Pol O., Puig M.M. Interaction between tramadol and two anti-emetics on nociception and gastrointestinal transit in mice. Eur J Pain 2006, 10:629-638.
3. Gan S.H., Ismail R., Wan Adnan W.A., Wan Z. Method development and validation of a high-performance liquid chromatographic method for tramadol in human plasma using liquid-liquid extraction. J Chromatogr B Anal Technol Biomed Life Sci 2002, 772:123-129.
4. Grond S., Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet 2004, 43:879-923.
5. Hinchcliffe M., Illum L. Intranasal insulin delivery and therapy. Adv Drug Deliv Rev 1999, 35:199-234.
6. Lewis K.S., Han N.H. Tramadol: a new centrally acting analgesic. Am J Health Syst Pharm 1997, 54:643-652.
7. Pinardi G., Pelissier T., Miranda H.F. Interactions in the antinociceptive effect of tramadol in mice: an isobolographic analysis. Eur J Pain 1998, 2:343-350.